Corpus Intelligence IC Memo — GREENVIEW REGIONAL HOSPITAL 2026-04-26 04:04 UTC
IC Memo — GREENVIEW REGIONAL HOSPITAL
Investment Committee Memorandum | KY | 118 beds | Grade C | EBITDA uplift $10.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GREENVIEW REGIONAL HOSPITAL

CCN 180124 | WARREN, KY | 118 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

GREENVIEW REGIONAL HOSPITAL is a 118-bed suburban community hospital in WARREN, KY with $146.2M in net patient revenue and a 17.8% operating margin. The hospital serves a payer mix of 33.1% Medicare, 0.9% Medicaid, and 66.0% commercial.

Thesis: Turnaround. Our ML models identify $10.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.8% to 25.1% (+736bps).

Net Revenue HCRIS$146.2M
Current EBITDA COMPUTED$26.0M
Operating Margin COMPUTED17.8%
Occupancy HCRIS52.5%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS14.9%
Distress Probability ML45.3%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
41
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 17.8% places it above the state median. Among 41 size-comparable peers (59-236 beds), the median margin is 0.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (59-236), prioritizing same-state peers. 41 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GREENVIEW REGIONAL HOSPITAL (Target)KY118$146.2M17.8%
BAPTIST HEALTH PADUCAHKY190$391.7M-0.5%
MERCY HEALTH LOURDES HOSPITAL KY178$288.1M7.7%
BAPTIST HEALTH CORBINKY197$285.4M1.4%
LAKE CUMBERLAND REGIONAL HOSPKY179$278.7M5.6%
BAPTIST HEALTH MADISONVILLEKY154$220.0M-5.7%
ST. ELIZABETH FLORENCEKY134$212.6M8.8%
SAINT JOSEPH EASTKY138$209.5M2.6%
EPHRAIM MCDOWELL REG MED CTRKY157$207.7M-13.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.1M+210bp18mo
Cost to Collect4.5%2.5%$2.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.8M+122bp9mo
Clean Claim Rate88.0%96.0%$94K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.1M
Cost to Collect
$2.9M
Denial Rate Reduction
$2.9M
A/R Days Reduction
$1.8M
Clean Claim Rate
$94K
Total EBITDA Uplift$10.8M
Current EBITDA$26.0M
+ RCM Uplift+$10.8M
Pro Forma EBITDA$36.7M
Current Margin17.8%
Pro Forma Margin25.1%
WC Released (1x)$5.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$39.9M$278.8M6.98x47.5%
Base (11x exit)10.0x11.0x$39.9M$319.7M8.00x51.6%
Bull Case9.0x11.0x$35.9M$368.1M10.24x59.2%
Bull (12x exit)9.0x12.0x$35.9M$412.2M11.47x62.9%
Bear Case11.0x10.0x$43.9M$212.1M4.83x37.0%
Bear (11x exit)11.0x11.0x$43.9M$247.5M5.63x41.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 41 hospitals with 59-236 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-9.6% / P50=0.7% / P75=10.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.